Ezzeldin assumed his current position at CHG in 2015. The company today holds majority stakes in and operates seven hospitals in Cairo, two polyclinics, and a majority stake in Bedaya for Medical Services, Egypt’s IVF and Fertility Centre. As of March 2024, CHG had around 800 beds, with plans to introduce 300 more in 2025, and serves around 1.2 million cases annually. In April 2024, the group partnered with the Mumtada Medical Company to launch a 200-bed rehabilitation facility in Riyadh, Saudi Arabia. In Q1 2024, CHG generated $24 million in revenues, an increase of 52% compared to Q1 2023. Ezzeldin previously oversaw government affairs and policy for MENA and Pakistan at Johnson & Johnson.